Page 7 - U.S. Pharmaceuticals & Biotech Stocks - Top Gainers Today

Company	Last Price	1D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
CAPR Capricor Therapeutics	US$19.06	1.3%	543.9%	US$855.7m	US$41.29	PS37.3x	E67.6%	n/a
BTMD biote	US$6.69	5.5%	32.7%	US$197.3m	US$9.54	PE29x	E64.8%	n/a
ETON Eton Pharmaceuticals	US$12.45	3.5%	233.8%	US$310.8m	US$15.00	PS9.3x	E59.1%	n/a
VRCA Verrica Pharmaceuticals	US$1.11	12.0%	-70.3%	US$89.7m	US$6.33	PS10.9x	E60.4%	n/a
RIGL Rigel Pharmaceuticals	US$26.70	2.3%	161.8%	US$459.6m	US$29.17	PE121.2x	E43.3%	n/a
FENC Fennec Pharmaceuticals	US$6.04	6.7%	-29.2%	US$155.2m	US$13.60	PS3.4x	E63.7%	n/a
CTOR Citius Oncology	US$1.00	17.2%	-90.9%	US$60.6m	n/a	PB4.2x	n/a	n/a
LENZ LENZ Therapeutics	US$36.25	1.0%	n/a	US$986.7m	US$39.29	PB4.6x	E41.0%	n/a
PROC Procaps Group	US$1.36	7.1%	-43.8%	US$143.3m	n/a	PE2.9x	n/a	n/a
EOLS Evolus	US$12.83	1.3%	34.5%	US$802.3m	US$23.43	PS3.3x	E73.9%	n/a
CDXC ChromaDex	US$7.59	1.7%	430.8%	US$571.1m	US$7.96	PE391.3x	E81.8%	n/a
CGEN Compugen	US$1.52	7.8%	135.6%	US$126.2m	US$4.00	PE85.1x	E-59.8%	n/a
PEPG PepGen	US$4.78	6.7%	5.1%	US$146.0m	US$16.20	PB1.1x	E-1.8%	n/a
EBS Emergent BioSolutions	US$10.03	1.8%	399.0%	US$533.7m	US$12.00	PB1.1x	E98.5%	n/a
ARTV Artiva Biotherapeutics	US$12.21	3.4%	n/a	US$286.9m	US$21.25	PS114x	E-20.6%	n/a
SCPH scPharmaceuticals	US$3.60	5.6%	-33.6%	US$170.6m	US$18.00	PS5.9x	E69.8%	n/a
EWTX Edgewise Therapeutics	US$32.08	0.3%	435.6%	US$3.0b	US$43.43	PB6.2x	E-5.4%	n/a
YMAB Y-mAbs Therapeutics	US$10.77	2.0%	85.7%	US$473.0m	US$21.00	PS5.7x	E-22.8%	n/a
CAMP Camp4 Therapeutics	US$4.94	10.8%	n/a	US$87.0m	US$20.16	PE-1.9x	E-8.7%	n/a
PSNL Personalis	US$3.73	3.6%	126.1%	US$254.3m	US$7.02	PS3x	E37.9%	n/a
GLUE Monte Rosa Therapeutics	US$8.60	1.7%	190.5%	US$519.7m	US$16.43	PS35.3x	E20.1%	n/a
SVRA Savara	US$3.46	1.5%	-3.9%	US$585.2m	US$9.79	PB3x	E52.5%	n/a
INBX Inhibrx Biosciences	US$15.45	4.0%	n/a	US$215.1m	n/a	PE0.1x	n/a	n/a
AZTA Azenta	US$45.76	0.4%	-19.5%	US$2.1b	US$56.60	PS3.2x	E125.6%	0%